340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Hospital Groups Challenge Denial of Retroactive 340B Discounts

Policy is at odds with congressional intent and HRSA's past guidance, they say.
 

Print Article

January 19, 2011—The Office of Pharmacy Affairs’ (OPA) decision that rural hospitals cannot seek 340B drug discounts on purchases between Jan. 1, 2010 and their enrollment in the program contradicts congressional intent and the office’s own past guidance, three hospital groups maintained in a Jan. 11 letter to the Health Resources and Services Administration (HRSA).

Safety Net Hospitals for Pharmaceutical Access (SNHPA), the American Hospital Association (AHA) and the National Rural Health Association (NRHA) sent the letter in response to guidance that OPA published last September on its Web site’s “frequently asked questions” page.

Law’s Effective Date

The section of health care reform that extended 340B eligibility to rural hospitals had an effective date of Jan. 1, 2010 and stated that the program’s expansion “shall apply to drugs purchased on or after” that date. OPA’s guidance, however, stated that a provider’s eligibility begins only when it is fully enrolled, assigned a 340B identification number and listed in the 340B database.

Enrollment for the new categories of 340B entities opened on Aug. 2, seven months after their eligibility began. About 850 hospitals and affiliated sites have been added to the program under health reform, the vast majority of them rural.

Industry Anticipated Payments

The hospital groups said they object to the guidance because it directly conflicts with health reform’s plain language. The drug industry itself recognized Congress’s intent to require retroactive relief, they noted. As the Monitor has previously reported, some major drug manufacturers stated publicly this fall that they were required to provide the retroactive discounts, and at least one, Eli Lilly and Co., set aside $40 million to pay for them. Lilly added that amount back to its budget after learning of OPA’s guidance.

The hospital groups also challenged the guidance on the grounds that it contradicts past HRSA guidance. HRSA allowed new 340B covered entities to receive retroactive discounts both when the program first began in 1992 and again in 2009, when children’s hospitals became eligible for the program. The letter urged HRSA to allow newly-enrolled rural hospitals to obtain retroactive discounts under the same process it established for children’s hospitals.

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS 340B Employed

  • Pharmacy Business Manager | Nemours Children's Health April 7, 2026
  • 340B Compliance Auditor | Geisinger April 6, 2026
  • Coordinator Pharmacy 340B Program - General Pharmacy - Full Time | CHRISTUS Health April 6, 2026
  • Pharmacy Procurement Analyst | Denver Health April 6, 2026
  • 340B Director - Milwaukee, WI | Ascension March 24, 2026

Copyright © 2026 · 340B Health